JACQUELINE MILLER, M.D.

Jacqueline Miller is the Head of Development for Infectious Diseases where she leads the team responsible for Phase 1-4 development of vaccine candidates.  She led the development team for Spikevax, Moderna’s COVID-19 vaccine, and has brought three additional programs to Phase 3 development since joining Moderna 3 years ago.  Previously, she spent 15 years at GSK Vaccines where she contributed to the development and launch of 5 novel vaccines and most recently was Head of US Vaccine Clinical R&D at GSK until 2020.  She trained as a pediatrician at Children’s Hospital of Philadelphia after medical school at Northwestern University, and has spent the last 23 years in vaccine development.